First Case of Emergence of Atovaquone Resistance in Plasmodium falciparum during Second-Line Atovaquone-Proguanil Treatment in South America-Reference-Cited by-同舟云学术

First Case of Emergence of Atovaquone Resistance in Plasmodium falciparum during Second-Line Atovaquone-Proguanil Treatment in South America

Published:2007-06 Issue:6 Volume:51 Page:2280-2281
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Legrand Eric¹,Demar Magalie²,Volney Béatrice¹,Ekala Marie-Thérèse³,Quinternet Marc¹,Bouchier Christiane⁴,Fandeur Thierry⁵,Rogier Christophe⁶,Carme Bernard²,Puijalon Odile Mercereau³,Esterre Philippe¹

Affiliation:

1. Centre National de Référence sur la Chimiorésistance du Paludisme dans la région Antilles-Guyane  Institut Pasteur de la Guyane  BP 6010  F-97306 Cayenne-Cedex, French Guiana

2. Laboratoire Hospitalo-Universitaire de Parasitologie et Mycologie  Faculté de Médecine Antilles-Guyane et Centre Hospitalier de Cayenne  Equipe EA 3593  Cayenne, French Guiana

3. Unité d'Immunologie Moléculaire des Parasites  CNRS URA 2581  Institut Pasteur  25 rue du Docteur Roux  75724 Paris Cedex 15, France

4. Pasteur Genopole Ile de France  Institut Pasteur  25 rue du Docteur Roux  75724 Paris Cedex 15, France

5. Faculté de Pharmacie  UFR sciences pharmaceutiques  UMR INRA-Université d'Immunologie Parasitaire et de Vaccinologie  Tours, France

6. Unité de recherche en Biologie et Epidémiologie Parasitaire  Institut de Medecine Tropicale du Service de Santé des Armées  Marseille, France

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01532-06

Reference12 articles.

1. Bogreau, H., F. Renaud, H. Bouchiba, P. Durand, S.-B. Assi, M.-C. Henry, E. Garnotel, B. Pradines, T. Fusai, B. Wade, E. Adehossi, P. Parola, M. Ali Kamil, O. Mercereau-Puijalon, and C. Rogier. 2006. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am. J. Trop. Med. Hyg.74:953-959.

2. Fivelman, Q. L., G. A. Butcher, I. S. Adagu, D. C. Warhurst, and G. Pasvol. 2002. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate Lagos, Nigeria. Mal. J.1:1-4.

3. Foote, S. J., D. Galatis, and A. F. Cowman. 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA87:3014-3017.

4. Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site

5. Kuhn, S., M. J. Gill, and K. C. Kain. 2005. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune North American traveller to West Africa. Am. J. Trop. Med. Hyg.72:407-409.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum;Antimicrobial Agents and Chemotherapy;2023-06-15

2. Structural Analysis of the Plasmodial Proteins ZNHIT3 and NUFIP1 Provides Insights into the Selectivity of a Conserved Interaction;Biochemistry;2022-03-22

3. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2017-12-11

4. Résistance acquise à l’atovaquone-proguanil dans un cas importé d’accès palustre simple à Plasmodium falciparum chez un jeune enfant;La Presse Médicale;2017-03

5. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine;Antimicrobial Agents and Chemotherapy;2016-01